In tumor cells of the lesion, the factor XIIIa positivity confirms dermal dendrocyte differentiation, the neoplastic component central to dermatofibroma formation, while CD34 negativity excludes vascular proliferation and aids in distinguishing MEDFs from DFSP. This evidence concerns the gene CD34 and cutaneous fibrous histiocytoma.